Advertisement

Experientia

, Volume 31, Issue 8, pp 894–896 | Cite as

Influence of methylxanthines on aniline disappearance and metabolism in rats

  • H. U. Aeschbacher
Specialia Chimica, Biochimica

Keywords

Enzyme Aniline Methylxanthine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Zusammenfassung

Eine Induktion der Mikrosomalenzyme der Leber, gemessen in vitro, wurde beobachtet, wenn hohe Dosen von Methylxanthinen an Ratten verabreicht wurde. Wenn den Versuchstieren gleich hohe Dosen von den obengenannten Substanzen verabreicht wurden, die Aktivität der arzneimittelabbauenden Enzyme jedoch in vivo gemessen wurde, so war kein Unterschied zur Kontrollgruppe festzustellen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    G. J. Mannering, inSelected Pharmacological Testing Methods (Ed.A. Burger; Marcel Dekker, New York 1968).Google Scholar
  2. 2.
    T. C. Campbell andJ. R. Hayes, Pharmac. Rev.26, 171 (1974).Google Scholar
  3. 3.
    A. H. Conney, Pharmac. Phys.3, 1 (1969).Google Scholar
  4. 4.
    C. Mitoma, T. J. Sorich II, andS. E. Neubauer, Life Sc.7, 145 (1968).Google Scholar
  5. 5.
    C. Mitoma, L. Lombrozo, S. E. Le Valley andF. Dehn, Arch. Biochem. Biophys.134, 434 (1969).PubMedCrossRefGoogle Scholar
  6. 6.
    K. L. Khanna andH. H. Cornish, Fd. Cosmet. Toxic.11, 11 (1973).Google Scholar
  7. 7.
    J. R. Fouts, Toxic. appl. Pharmac.16, 48 (1970).CrossRefGoogle Scholar
  8. 8.
    K. S. Rao, E. A. Glende andR. O. Recknagel, Expl. molec. Pharmac.12, 324 (1970).Google Scholar
  9. 9.
    D. Gilbert andL. Goldberg, Fd. Cosmet. Toxic.3, 417 (1965).Google Scholar
  10. 10.
    T. Omura andR. Sato, J. biol. Chem.239, 2370 (1964).PubMedGoogle Scholar
  11. 11.
    O. H. Lowry, N. J. Rosebrough, A. L. Farr andR. J. Randall, J. biol. Chem.193, 265 (1951).PubMedGoogle Scholar
  12. 12.
    J. R. Gillette, inAdvances in Pharmacology (Eds.S. Garattini andP. A. Shorev; Academic Press, New York 1966), vol. 4 p. 219.Google Scholar
  13. 13.
    B. Hach andF. Heim, Arzneimitt. Forsch.21, 23 (1971).Google Scholar
  14. 14.
    H. U. Aeschbacher, J. Atkinson andB. Domahidy, J. Pharmac. exp. Ther.192, 635 (1975).Google Scholar
  15. 15.
    R. Kuntzman, A. Rev. Pharmac.9, 21 (1969).CrossRefGoogle Scholar
  16. 16.
    A. Y. H. Lu andW. Levin, Biochim. biophys. Acta344, 205 (1974).PubMedGoogle Scholar
  17. 17.
    J. R. Fouts andB. B. Brodie, J. Pharmac. exp. Ther.115, 68 (1955).Google Scholar
  18. 18.
    M. Ikeda, S. Tanaka andT. Katayama, Molec. Pharmac.4, 38 (1968).Google Scholar
  19. 19.
    H. Remmer, Am. J. Med.49, 617 (1970).PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag 1975

Authors and Affiliations

  • H. U. Aeschbacher
    • 1
  1. 1.Biological LaboratoriesNestlé Products Technical Assistance Company LimitedOrbe(Switzerland)

Personalised recommendations